Definitive surgery of primary lesion should be prioritized over preoperative chemotherapy to treat high-grade osteosarcoma in patients aged 41–65 years
Keiko Hayakawa(Cancer Institute (WIA)), Atsushi Okawa(Research Institute of Economy, Trade and Industry), Seiichi Matsumoto(Fukuda Denshi (Japan)), Taisuke Tanizawa(Japanese Foundation For Cancer Research), Yusuke Minami(Hokkaido University), Yuki Funauchi(Japan Association for Development of Community Medicine), Keisuke Ae(The Cancer Institute Hospital), Masanori Saito(Japanese Foundation For Cancer Research)
Cited by 11
Related Papers
Clear Cell Sarcoma of Soft Tissue
|The American Journal of Surgical Pathology|2008|283
Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A
|Proceedings of the National Academy of Sciences|2018|264
Carbon Ion Radiation Therapy for Unresectable Sacral Chordoma: An Analysis of 188 Cases
|International Journal of Radiation Oncology*Biology*Physics|2016|182
Vitamin E decreases bone mass by stimulating osteoclast fusion
|Nature Medicine|2012|174
Regulation of iron homeostasis by the p53-ISCU pathway
|Scientific Reports|2015|108